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in Australia’s Antarctic Territory.
Method
The Australian Antarctic Division has been providing medical support for it’s 
expeditions in the Antarctic for some 60 years. This breadth of experience 
has provided a large epidemiological evidence base which informs the 
nature of Antarctic and expedition medicine.
Conclusion
Antarctic medicine is the practice of medicine in the extreme hostile 
environment of Antarctic. It is characterized by barriers of sea ice, extreme 
cold, wind and seasonal winter darkness. Unique considerations should 
be part of the travel medicine provider’s assessment of those wishing to 
join expeditions to the Antarctic. Antarctic medicine is arguably the most 
isolated medical practice on earth!
PAPUA NEw GUINEA: DISEASE EPIDEMIoLoGY
H. Karunajeewa1
1 school of Medicine and pharmacology, University of Western Australia, perth, Australia
The leading causes of morbidity and mortality in papua New Guinea 
(pNG) include acute respiratory infection, malaria and tuberculosis. Of 
these, malaria constitutes by far the greatest threat to visitors and resident 
expatriates. plasmodium falciparum, vivax, ovale and malariae are all 
endemic throughout the country but their epidemiology varies widely 
throughout this geographically diverse country. Altitude is the principal 
determinant of disease prevalence. Transmission of p.falciparum ranges 
from being absent in ‘highlands’ regions above 1700m to unstable/
epidemic at intermediate altitudes and then hyper- and holoendemic 
in coastal lowland regions. The latter have some of the highest rates of 
transmission recorded worldwide. However, in spite of this, transmission 
within the principal coastal towns themselves (including port Moresby, Lae 
and Madang) may be relatively low. p.falciparum resistance to affordable 
conventional antimalarials (chloroquine and anti-folates) represents a 
significant challenge to local treatment policies. However this population 
has not had significant exposure to newer agents (including mefloquine, 
atovaquone and lumefantrine) which are likely to remain effective. Rates 
of p.vivax resistance to chloroquine and primaquine are also now high. In 
addition to malaria, other endemic vector borne diseases include filariasis 
in remote rural areas and dengue, which is probably endemic throughout 
much of coastal pNG. Japanese encephalitis has been described in at least 
two geographically separate locations but its distribution throughout the 
country and its contribution to human disease remain unknown. sexually 
transmitted infections including gonnorhoea, chlamydia, donovanosis 
and syphilis are highly prevalent. HIV prevalence continues to rise at an 
alarming rate with the highest rates in large urban centres (port Moresby, 
Lae and Mt Hagen). Food and water-borne disease ranks fairly low as a 
cause of morbidity and mortality in pNG. However typhoid is prevalent 
particularly in peri-urban settlements and in the more densely populated 
regions of the highlands.
THE TRAVEL MEDICINE CoNSULTATIoN
A. Gherardin1
1 Travel Doctor-TMVC Australia
The consultation with the travel medicine service provider and the traveller 
is the foundation of the process of travel medicine, and provides the 
analysis of risk upon which all specific preventive advice and interventions 
are subsequently based. The interaction is a complex one, and practitioners 
must provide appropriate time, location and resources in order to maximise 
the usefulness. Understanding the phases of the travel experience, some 
basic aspects of the psychology of travel and preventive health behaviour, 
and ensuring processes can be flexible are important considerations. 
Different models of consultations are employed in different legislatures 
around the world, and this has some impact on the nature of the consultation. 
A core aspect of the process of risk assessment includes taking a detailed 
medical and personal history of the traveller relevant to travel medicine, 
obtaining a detailed assessment of the itinerary, destinations, proposed 
activities, accommodation, and duration of travel, and reviewing previous 
immune status of the traveller. Factors relating to the traveller, the itinerary 
and the destination, must all be considered. Cost implications must be 
discussed. The risk assessment should guide the recommendations for 
specific advice and information, vaccination, chemoprophylaxis, medical 
kits and other preventive interventions. Individuals with higher-risk 
factors should be specifically identified and managed. Travel medicine 
practitioners should ideally possess a relevant knowledge of travellers 
morbidity, both communicable and non-communicable, epidemiology 
of emerging illness, vaccinology, geography, and management of post-
travel illness. In addition, practitioners should provide within the context 
of the consultation the necessary vaccines, medications, and preventive 
products. providing some vaccines as per a destination country list alone 
is not good travel medicine, and a quality travel medicine consultation 
must represent a complex and comprehensive response to an organised, 
structured process. This presentation discusses this process.
SPECIAL TRAVELLERS
P. Batchelor1
1 Medical Officer, sOs International Clinic, Ho Chi Minh, Vietnam
objective
This presentation will outline the basic issues facing special travellers such 
as children, pregnant women and the immunocompromised.
Method
A summary of current recommendations, and their rationales, based on 
literature review will be presented.
Result
A greater understanding of the particular risks faced by these special 
travellers.
Conclusion
special travellers have special needs in relation to all aspects of their travel 
health – pre, post and during. Issues include vaccine safety and efficacy, 
exacerbation of pre-exiting conditions, increased susceptibility to illness 
overseas and implications for post travel care.
SPECIAL ITINERARIES
N. Zwar1
1 University of New south Wales school of public Health and Community Medicine,   
Australia
objective
people often engage in activities during travel that they do not undertake 
in their countries of origin. pre travel health advice needs to be tailored 
to risks of a diverse range of itineraries and activities undertaken during 
travel. This is an integral part of the three Ts risk assessment process of 
considering travel health advice for this traveller, this trip and this time.
Method
The presentation will cover risk assessment for travellers with special 
itineraries.
Result
Issues covered in the presentation are the last minute traveller, the 
frequent traveller, backpacking and long term travel. The presentation will 
cover issues of providing advice to travellers who plan to visit high risk 
destinations for infectious diseases such as Africa. As well as considering 
the itinerary the presentation will also cover risk assessment and advice for 
travellers planning special activities such as surfing, diving and caving. Risk 
assessment and advice on high altitude travel will also be considered.
Conclusion
providing advice to travellers with special itineraries involves well developed 
skills in risk assessment and tailoring advice to the travellers, the trip and 
the time.
CASES IN PRE-TRAVEL
D.B. Cowie1, A. De Frey2
1 Fairfield Travel Health, Royal Melbourne Hospital; VIDRL; University of Melbourne
2 Royal Melbourne Hospital 
An interactive case-based program exploring important themes in pre-
travel assessment and management. A number of illustrative real-life case 
examples will provide the foundation for further discussion and audience 
participation.
REGIoNAL TRAINING IN TRoPICAL AND TRAVEL MEDICINE
P.A. Leggat1
1 Anton Breinl Centre, James Cook University, Townsville, Australia
objectives
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To review regional training initiatives in travel and tropical medicine.
Methods
standard searches on pubMed, CINAHIL and Google were conducted 
looking at key words training, education, academic, professional, travel 
medicine and tropical medicine, primarily focusing on Australia and New 
Zealand and our regional neighbours.
Results
Australia has a long tradition of academic training in tropical medicine 
dating back to 1925. since then, major programs in tropical medicine have 
arisen elsewhere in the region, including the University of the Medical 
sciences (now Mahidol University) in 1961, which is also part of the 
sEAMEO TROpMED Network. A professional college of tropical medicine 
was established in Australia in 1991. Both Australia and New Zealand 
offer academic programs in travel medicine. Following the establishment 
of the Asia pacific Travel Health society, a professional faculty of travel 
medicine was established in Australia in 2000. Various organizations now 
offer continuing professional development programs in tropical and travel 
medicine throughout the region. Linkages are just starting to form with 
licensing and statutory requirements for training, for example with yellow 
Fever Vaccination Centres in New Zealand, which may assist in the uptake 
of academic and professional training in tropical and travel medicine.
Conclusions
Extensive opportunities exist for academic and professional training 
in tropical medicine in the region. professional and commercial groups 
should advocate for appropriate training requirements for those entering 
the field of travel medicine and for continuing professional development.
hAJJ MEDICINE
Z.A. Memish1
1 King Abdulaziz Medical City, King Fahad National Guard Hospital, Riyadh, Kingdom of   
saudi Arabia
Hajj is the greatest assembly of humankind on earth. More than 2.5 million 
Muslims attend Hajj every year. In this epic pilgrimage, millions of Muslims 
make a visit to the Ka’aba, (the house of God) and surrounding Holy sites. 
Over a number of days, their struggle becomes both literal and metaphysical. 
While he seeks to offer prayer, the pilgrim must also struggle against 
distinct environmental and public health hazards throughout the journey. 
These hazards have been repeatedly recorded in the literature for over a 
hundred years. Today we can learn much from Hajj. pilgrimage presents a 
unique opportunity to study health issues in a mobile population. Due to 
massive scale and singular focus on one city, Hajj affords insights no other 
migration can yet offer. substantial hazards accompany such extraordinary 
congestion. Rather than a onetime annual undertaking, Hajj planning has 
become a year-long cycle of preparation, both for the host nation, saudi 
Arabia, as well as nations sending pilgrims on the journey. planning for 
mass migration on such a colossal scale demands collective enthusiasm 
and cooperation on an unprecedented scale, both between individuals and 
nation-states. This ‘good behavior’ (care for the other pilgrim, aiding the 
weak, guiding the infirm, and the countenance of deference required by 
God of the Muslim in Hajj) is probably the most powerful check to immense 
dangers a crowd of 2 million could otherwise present. prolonged stays at 
Hajj sites, the prevailing climate of heat and humidity and shared sleeping 
accommodation in tents encourage disease transmission, especially that 
of airborne agents. Overwhelming vehicular and population congestion, 
together with inadequately prepared or stored foods add to attendant 
health risks. Hazards can be communicable and non communicable. The 
congestion and the mass migration of the pilgrims bring a number of 
infectious processes to the fore. Meningococcal disease, respiratory tract 
infections, blood borne, diarrheal and zoonotic diseases all are frequently 
encountered problems for the pilgrims, either during Hajj or following 
Hajj. Unique occupational infections affect the abattoir worker at the Hajj 
and the Hajj barber, areas which are now firmly addressed by the saudi 
authorities. Most concerning are emerging infectious diseases (including 
sARs, and pandemic Avian Influenza) and their devastating potential to 
spread. Increasingly, international collaboration (in planning vaccination 
campaigns, developing visa quotas, arranging rapid repatriation, managing 
health hazards at the Hajj and providing care beyond the Holy sites) 
become essential. planning and supporting Hajj has become a forum for 
collaboration crossing any political considerations. The Kingdom remains 
very committed to its sovereignty over the Holy sites in order to safeguard 
the Hajj for the benefit of all Muslims around the globe.
PREPARING FoR BEIJING 2008
S. MacDonald1
1 Beijing United Family Hospital
In August 2008 Beijing will host the 29th summer Olympic Games with over 
600,000 foreign visitors and 1.1 million Chinese visitors predicted to visit 
the city. Concerns have been expressed internationally about the effects of 
air pollution on both athletes and visitors. Access to clean food and water 
as well as avoidance of infectious diseases also remain important issues for 
foreign visitors. This presentation will discuss the major health concerns 
that Beijing faces during the Olympic period and the various approaches 
that have been set up to minimize these problems. From changes in health 
care infrastructure to monitoring air quality and weather conditions, China 
has taken major steps to improve Beijing’s environment and access to 
resources during the Olympic Games. Familiarity with the 2008 Beijing 
Olympic preparations will be helpful for all travel health practitioners who 
advise travellers planning a visit to Beijing in August 2008.
HoST RISk FACToRS IN TRAVELLERS’ DIARRHEA AND PoST-
INFECTIoUS IRRITABLE BowEL DISEASE
H. L. DuPont 1,2,3
1 University of Texas – Houston school of public Health, Houston, Texas
2 st. Luke’s Episcopal Hospital, Houston, Texas
3 Baylor College of Medicine, Houston, Texas
Development of diarrhea during international travel appears to depend 
upon what persons do and who they are. With the knowledge that food 
and to a lesser degree beverages are the important sources of travellers’ 
diarrhea (TD), it is assumed although unproven that exercising care in 
what is consumed will reduce risk of acquiring TD. Recent studies provide 
evidence that host genetic factors influence rates of TD. The bacterial 
enteropathogens, which represent the major cause of TD, produce variable 
degrees of intestinal inflammation during illness. Host polymorphism in 
genes that control release of gut inflammatory markers, including lactoferrin 
from granules of polymorphonuclear leukocytes (pMNL) and IL-8, a 
precursor of pMNL, predict persons at special risk for TD. When compared 
with healthy U.s. students in Mexico and after adjustment for known risk 
factors for diarrhea, persons with T/T genotype in position codon 632 of 
the lactoferrin gene had a rate of TD of 67% vs. 33% for other genotypes. 
The chance of developing TD due to enteroaggregative E. coli (EAEC) was 
significantly increased among U.s. students with the AA genotype at the 
-251 position of IL-8 gene compared with other genotypes (OR 208.51; 
95% CI, 28.5-1525.36). In a group of 97 students from the U.s. in Mexico, 
our group found that 61 (63%) experienced TD. six months later 6 (10%) 
of those having experienced diarrhea earlier in Mexico met the Rome II 
criteria for new onset post-infectious irritable bowel syndrome (pI-IBs). 
None of the students not having experienced diarrhea were shown to have 
new onset IBs. In a separate study by stermer et al., primarily among 
international visitors to Asia, 16 of 118 (14%) experiencing TD and 7/287 
(2%) not having experienced TD were found to have pI-IBs 6-7 months 
later (p <.0001; RR 5.2; 95% CI, 2.2- 12.3). Other studies have shown 
that once pI-IBs develops it can be expected to last years to decades. 
Until we are able to identify persons at greatest risk for TD and pI-IBs 
during international travel, we should assume all are susceptible to both. 
Education of future travellers to avoid higher-risk foods and beverages, 
research into the value of such restrictions and developing ways to achieve 
improved compliance with the recommendations are needed. Until we have 
effective ways to predict the persons at special risk and or effective means 
to prevent the illness, it is this author’s opinion that we in travel medicine 
should consider more liberal use of chemoprophylaxis and to pursue the 
development of vaccines against this common illness.
EPIDEMIoLoGY AND ETIoLoGY oF TRAVELLER’S DIARRHoEA IN 
SoUTHEAST ASIA
V. Chongsuvivatwong1, T. Kalambaheti2, S. Chariyalertsak3, E. McNeil1, S. 
Aiyarak4, S. Hutamai5, S. Thithipuree6, Z. Jiang2, H.L. DuPont7,  R. Steffen8 
1 Epidemiology Unit, Faculty of Medicine, prince of songkla University, Hatyai, Thailand
2 Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
3 Research Institute for Health science, Chiangmai University, Thailand
